Alto Neuroscience (ANRO) Earnings Date, Estimates & Call Transcripts $11.04 -0.15 (-1.30%) As of 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Alto Neuroscience Earnings Summary Alto Neuroscience announced Q2 2025 earnings on August 13, 2025, reporting an EPS of -$0.65, which missed analysts' consensus estimates of -$0.57 by $0.08. With a trailing EPS of -$2.39, Alto Neuroscience's earnings are expected to grow next year, from ($2.54) to ($2.39) per share. Upcoming Q3 Earnings DateNov. 11Before Market OpensEstimatedConsensus EPS (Aug. 13) -$0.57 Actual EPS (Aug. 13) -$0.65 Missed By -$0.08 Q2 2025 Earnings ResourcesQ2 2025 Earnings Report Press Release (8-K) Quarterly Report (10-Q)ANRO Upcoming EarningsAlto Neuroscience's Q3 2025 earnings is scheduled for Tuesday, November 11, 2025, with a conference call scheduled on Wednesday, November 12, 2025 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Powered by Get Alto Neuroscience Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Alto Neuroscience and other key companies, straight to your inbox. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Skip Charts & View Estimated and Actual Earnings DataANRO Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter. Alto Neuroscience Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateQ1 20253-$0.67-$0.45-$0.57Q2 20253-$0.68-$0.50-$0.58Q3 20252-$0.69-$0.64-$0.67 2025 8 -$2.04 -$1.59 -$1.81 Q3 20261-$0.50-$0.50-$0.50Q4 20261-$0.51-$0.51-$0.51 Alto Neuroscience Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 11/11/2025(Estimated)--------8/13/2025Q2 2025-$0.57-$0.65 -$0.08-$0.65--5/13/2025Q1 2025-$0.59-$0.53+$0.06-$0.56--3/20/2025Q4 2024-$0.65-$0.56+$0.09-$0.56--11/12/2024--$0.67-$0.62+$0.05-$0.62--8/13/2024Q2 2024-$0.67-$0.60+$0.07-$0.60--5/14/2024Q1 2024-$0.46-$0.76 -$0.30-$0.76-- Alto Neuroscience Earnings - Frequently Asked Questions When is Alto Neuroscience's earnings date? Alto Neuroscience has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 11th, 2025 based off last year's report dates. Learn more on ANRO's earnings history. Did Alto Neuroscience beat their earnings estimates last quarter? In the previous quarter, Alto Neuroscience (NYSE:ANRO) missed the analysts' consensus estimate of ($0.57) by $0.08 with a reported earnings per share (EPS) of ($0.65). Learn more on analysts' earnings estimate vs. ANRO's actual earnings. How much profit does Alto Neuroscience generate each year? Alto Neuroscience (NYSE:ANRO) has a recorded net income of -$61.43 million. ANRO has generated -$2.39 earnings per share over the last four quarters. What is Alto Neuroscience's EPS forecast for next year? Alto Neuroscience's earnings are expected to grow from ($2.54) per share to ($2.39) per share in the next year. More Earnings Resources from MarketBeat Related Companies COMPASS Pathways Earnings Niagen Bioscience Earnings Siga Technologies Earnings Compass Therapeutics Earnings Savara Earnings KalVista Pharmaceuticals Earnings Bicycle Therapeutics Earnings CytomX Therapeutics Earnings REGENXBIO Earnings Monopar Therapeutics Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Freeport-McMoRan Posts Strong Earnings Despite Indonesia ShutdownTesla’s Earnings Review: Does the Juice Justify the Squeeze?Logitech Eyes Breakout Before Earnings—Citigroup Sees 30% UpsideLouis Vuitton Earnings Show Luxury Bull Market Isn’t Done YetGoldman Sachs Earnings Tell: Markets Seem OkayWhy Congress Is Buying Intuitive Surgical Ahead of Earnings3 Reasons to Buy Sprouts Farmers Market Ahead of Earnings This page (NYSE:ANRO) was last updated on 10/24/2025 by MarketBeat.com Staff From Our PartnersWhat a Former CIA Agent Knows About the Coming Collapse This isn’t just another gold investing book—it’s a survival playbook written by a former CIA officer trained...Advantage Gold | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredNEW LAW: Congress Approves Setup For Digital Dollar?Trump Ally Says Congress Approved the Setup for a Digital Dollar 2.0 But according to Rep. Marjorie Taylor ...Goldco Precious Metals | SponsoredMelt-up warning Porter Stansberry says this bull market is past the “safe zone” and racing toward an event horizon — and in hi...Porter & Company | SponsoredIt’s Time to Buy “the NVIDIA of Quantum Computing”Yahoo Finance wrote that investing in quantum computing could... "Lead to life-changing returns... and make...Brownstone Research | SponsoredMove $1,000 into this stock before Nov 6The End of Tesla? "Hold onto your Tesla stock." That's the message insiders at Tesla have been giving staff...Altimetry | SponsoredWhat Wall Street Won’t Say Out LoudDiscover the 7 key indicators before everyone else doesAmerican Alternative | SponsoredFree: The Crypto Summit That Could Change Your LifeFed cuts unleash crypto's next wave The smart money is already moving. This is your chance to see their car...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alto Neuroscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alto Neuroscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
